Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
Identifieur interne : 002698 ( Main/Exploration ); précédent : 002697; suivant : 002699Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
Auteurs : Carlos Rodriguez-Galindo ; Paola Friedrich ; Patricia Alcasabas ; Federico Antillon ; Shripad Banavali ; Luis Castillo ; Trijn Israels ; Sima Jeha ; Mhammed Harif ; Michael J. Sullivan ; Thuan Chong Quah ; Catherine Patte ; Ching-Hon Pui ; Ronald Barr ; Thomas GrossSource :
- Journal of Clinical Oncology [ 0732-183X ] ; 2015.
Descripteurs français
- KwdFr :
- Adolescent, Communication interdisciplinaire, Comportement coopératif, Coopération internationale, Diffusion des innovations, Disparités d'accès aux soins (tendances), Disparités de l'état de santé, Enfant, Facteurs temps, Humains, Induction de rémission, Jeune adulte, Oncologie médicale (tendances), Pédiatrie (tendances), Résultat thérapeutique, Santé mondiale (tendances), Survivants, Tumeurs (), Tumeurs (diagnostic), Tumeurs (ethnologie), Tumeurs (mortalité), Âge de début.
- MESH :
- diagnostic : Tumeurs.
- ethnologie : Tumeurs.
- mortalité : Tumeurs.
- tendances : Disparités d'accès aux soins, Oncologie médicale, Pédiatrie, Santé mondiale.
- Adolescent, Communication interdisciplinaire, Comportement coopératif, Coopération internationale, Diffusion des innovations, Disparités de l'état de santé, Enfant, Facteurs temps, Humains, Induction de rémission, Jeune adulte, Résultat thérapeutique, Survivants, Tumeurs, Âge de début.
English descriptors
- KwdEn :
- Adolescent, Age of Onset, Child, Cooperative Behavior, Diffusion of Innovation, Global Health (trends), Health Status Disparities, Healthcare Disparities (trends), Humans, Interdisciplinary Communication, International Cooperation, Medical Oncology (trends), Neoplasms (diagnosis), Neoplasms (ethnology), Neoplasms (mortality), Neoplasms (therapy), Pediatrics (trends), Remission Induction, Survivors, Time Factors, Treatment Outcome, Young Adult.
- MESH :
- diagnosis : Neoplasms.
- ethnology : Neoplasms.
- mortality : Neoplasms.
- therapy : Neoplasms.
- trends : Global Health, Healthcare Disparities, Medical Oncology, Pediatrics.
- Adolescent, Age of Onset, Child, Cooperative Behavior, Diffusion of Innovation, Health Status Disparities, Humans, Interdisciplinary Communication, International Cooperation, Remission Induction, Survivors, Time Factors, Treatment Outcome, Young Adult.
Abstract
Advances in the treatment of childhood cancers have resulted in part from the development of national and international collaborative initiatives that have defined biologic determinants and generated risk-adapted therapies that maximize cure while minimizing acute and long-term effects. Currently, more than 80% of children with cancer who are treated with modern multidisciplinary treatments in developed countries are cured; however, of the approximately 160,000 children and adolescents who are diagnosed with cancer every year worldwide, 80% live in low- and middle-income countries (LMICs), where access to quality care is limited and chances of cure are low. In addition, the disease burden is not fully known because of the lack of population-based cancer registries in low-resource countries. Regional and ethnic variations in the incidence of the different childhood cancers suggest unique interactions between genetic and environmental factors that could provide opportunities for etiologic research. Regional collaborative initiatives have been developed in Central and South America and the Caribbean, Africa, the Middle East, Asia, and Oceania. These initiatives integrate regional capacity building, education of health care providers, implementation of intensity-graduated treatments, and establishment of research programs that are adjusted to local capacity and local needs. Together, the existing consortia and regional networks operating in LMICs have the potential to reach out to almost 60% of all children with cancer worldwide. In summary, childhood cancer burden has been shifted toward LMICs and, for that reason, global initiatives directed at pediatric cancer care and control are needed. Regional networks aiming to build capacity while incorporating research on epidemiology, health services, and outcomes should be supported.
Url:
DOI: 10.1200/JCO.2014.60.6376
PubMed: 26304881
PubMed Central: 4979198
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 002E89
- to stream Pmc, to step Curation: 002D38
- to stream Pmc, to step Checkpoint: 000C64
- to stream PubMed, to step Corpus: 002945
- to stream PubMed, to step Curation: 002876
- to stream PubMed, to step Checkpoint: 002876
- to stream Ncbi, to step Merge: 002976
- to stream Ncbi, to step Curation: 002976
- to stream Ncbi, to step Checkpoint: 002976
- to stream Main, to step Merge: 002698
- to stream Main, to step Curation: 002698
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge</title><author><name sortKey="Rodriguez Galindo, Carlos" sort="Rodriguez Galindo, Carlos" uniqKey="Rodriguez Galindo C" first="Carlos" last="Rodriguez-Galindo">Carlos Rodriguez-Galindo</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Friedrich, Paola" sort="Friedrich, Paola" uniqKey="Friedrich P" first="Paola" last="Friedrich">Paola Friedrich</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Alcasabas, Patricia" sort="Alcasabas, Patricia" uniqKey="Alcasabas P" first="Patricia" last="Alcasabas">Patricia Alcasabas</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Antillon, Federico" sort="Antillon, Federico" uniqKey="Antillon F" first="Federico" last="Antillon">Federico Antillon</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Banavali, Shripad" sort="Banavali, Shripad" uniqKey="Banavali S" first="Shripad" last="Banavali">Shripad Banavali</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Castillo, Luis" sort="Castillo, Luis" uniqKey="Castillo L" first="Luis" last="Castillo">Luis Castillo</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Israels, Trijn" sort="Israels, Trijn" uniqKey="Israels T" first="Trijn" last="Israels">Trijn Israels</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Jeha, Sima" sort="Jeha, Sima" uniqKey="Jeha S" first="Sima" last="Jeha">Sima Jeha</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Harif, Mhammed" sort="Harif, Mhammed" uniqKey="Harif M" first="Mhammed" last="Harif">Mhammed Harif</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Sullivan, Michael J" sort="Sullivan, Michael J" uniqKey="Sullivan M" first="Michael J." last="Sullivan">Michael J. Sullivan</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Quah, Thuan Chong" sort="Quah, Thuan Chong" uniqKey="Quah T" first="Thuan Chong" last="Quah">Thuan Chong Quah</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Patte, Catherine" sort="Patte, Catherine" uniqKey="Patte C" first="Catherine" last="Patte">Catherine Patte</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Pui, Ching Hon" sort="Pui, Ching Hon" uniqKey="Pui C" first="Ching-Hon" last="Pui">Ching-Hon Pui</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Barr, Ronald" sort="Barr, Ronald" uniqKey="Barr R" first="Ronald" last="Barr">Ronald Barr</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Gross, Thomas" sort="Gross, Thomas" uniqKey="Gross T" first="Thomas" last="Gross">Thomas Gross</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26304881</idno><idno type="pmc">4979198</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979198</idno><idno type="RBID">PMC:4979198</idno><idno type="doi">10.1200/JCO.2014.60.6376</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">002E89</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002E89</idno><idno type="wicri:Area/Pmc/Curation">002D38</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002D38</idno><idno type="wicri:Area/Pmc/Checkpoint">000C64</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000C64</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">002945</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002945</idno><idno type="wicri:Area/PubMed/Curation">002876</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002876</idno><idno type="wicri:Area/PubMed/Checkpoint">002876</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002876</idno><idno type="wicri:Area/Ncbi/Merge">002976</idno><idno type="wicri:Area/Ncbi/Curation">002976</idno><idno type="wicri:Area/Ncbi/Checkpoint">002976</idno><idno type="wicri:doubleKey">0732-183X:2015:Rodriguez Galindo C:toward:the:cure</idno><idno type="wicri:Area/Main/Merge">002698</idno><idno type="wicri:Area/Main/Curation">002698</idno><idno type="wicri:Area/Main/Exploration">002698</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge</title><author><name sortKey="Rodriguez Galindo, Carlos" sort="Rodriguez Galindo, Carlos" uniqKey="Rodriguez Galindo C" first="Carlos" last="Rodriguez-Galindo">Carlos Rodriguez-Galindo</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Friedrich, Paola" sort="Friedrich, Paola" uniqKey="Friedrich P" first="Paola" last="Friedrich">Paola Friedrich</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Alcasabas, Patricia" sort="Alcasabas, Patricia" uniqKey="Alcasabas P" first="Patricia" last="Alcasabas">Patricia Alcasabas</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Antillon, Federico" sort="Antillon, Federico" uniqKey="Antillon F" first="Federico" last="Antillon">Federico Antillon</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Banavali, Shripad" sort="Banavali, Shripad" uniqKey="Banavali S" first="Shripad" last="Banavali">Shripad Banavali</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Castillo, Luis" sort="Castillo, Luis" uniqKey="Castillo L" first="Luis" last="Castillo">Luis Castillo</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Israels, Trijn" sort="Israels, Trijn" uniqKey="Israels T" first="Trijn" last="Israels">Trijn Israels</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Jeha, Sima" sort="Jeha, Sima" uniqKey="Jeha S" first="Sima" last="Jeha">Sima Jeha</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Harif, Mhammed" sort="Harif, Mhammed" uniqKey="Harif M" first="Mhammed" last="Harif">Mhammed Harif</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Sullivan, Michael J" sort="Sullivan, Michael J" uniqKey="Sullivan M" first="Michael J." last="Sullivan">Michael J. Sullivan</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Quah, Thuan Chong" sort="Quah, Thuan Chong" uniqKey="Quah T" first="Thuan Chong" last="Quah">Thuan Chong Quah</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Patte, Catherine" sort="Patte, Catherine" uniqKey="Patte C" first="Catherine" last="Patte">Catherine Patte</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Pui, Ching Hon" sort="Pui, Ching Hon" uniqKey="Pui C" first="Ching-Hon" last="Pui">Ching-Hon Pui</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Barr, Ronald" sort="Barr, Ronald" uniqKey="Barr R" first="Ronald" last="Barr">Ronald Barr</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author><author><name sortKey="Gross, Thomas" sort="Gross, Thomas" uniqKey="Gross T" first="Thomas" last="Gross">Thomas Gross</name><affiliation><nlm:aff id="aff1">Carlos Rodriguez-Galindo and Paola Friedrich, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Patricia Alcasabas, Philippines General Hospital, Manila, Philippines; Federico Antillon, Unidad Nacional de Oncología Pediátrica, and Francisco Marroquín Medical School, Guatemala City, Guatemala; Shripad Banavali, Tata Memorial Hospital, Mumbai, India; Luis Castillo, Hospital Pereira Rossell, Montevideo, Uruguay; Trijn Israels, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Sima Jeha and Ching-Hon Pui, St Jude Children's Research Hospital, Memphis, TN; Mhammed Harif, Centre Hospitalier Universitaire Mohammed VI, Marrakech, Morocco; Michael J. Sullivan, Royal Children's Hospital, Melbourne, Australia; Thuan Chong Quah, National University Health System, Singapore; Catherine Patte, Institute Gustave-Roussy, Villejuif, France; Ronald Barr, McMaster University and McMaster Children's Hospital, Hamilton, ON, Canada; and Thomas Gross, National Cancer Institute Center for Global Health, Bethesda, MD.</nlm:aff><wicri:noCountry code="subfield">MD.</wicri:noCountry></affiliation></author></analytic><series><title level="j">Journal of Clinical Oncology</title><idno type="ISSN">0732-183X</idno><idno type="eISSN">1527-7755</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Age of Onset</term><term>Child</term><term>Cooperative Behavior</term><term>Diffusion of Innovation</term><term>Global Health (trends)</term><term>Health Status Disparities</term><term>Healthcare Disparities (trends)</term><term>Humans</term><term>Interdisciplinary Communication</term><term>International Cooperation</term><term>Medical Oncology (trends)</term><term>Neoplasms (diagnosis)</term><term>Neoplasms (ethnology)</term><term>Neoplasms (mortality)</term><term>Neoplasms (therapy)</term><term>Pediatrics (trends)</term><term>Remission Induction</term><term>Survivors</term><term>Time Factors</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Communication interdisciplinaire</term><term>Comportement coopératif</term><term>Coopération internationale</term><term>Diffusion des innovations</term><term>Disparités d'accès aux soins (tendances)</term><term>Disparités de l'état de santé</term><term>Enfant</term><term>Facteurs temps</term><term>Humains</term><term>Induction de rémission</term><term>Jeune adulte</term><term>Oncologie médicale (tendances)</term><term>Pédiatrie (tendances)</term><term>Résultat thérapeutique</term><term>Santé mondiale (tendances)</term><term>Survivants</term><term>Tumeurs ()</term><term>Tumeurs (diagnostic)</term><term>Tumeurs (ethnologie)</term><term>Tumeurs (mortalité)</term><term>Âge de début</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="ethnologie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="ethnology" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Disparités d'accès aux soins</term><term>Oncologie médicale</term><term>Pédiatrie</term><term>Santé mondiale</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Global Health</term><term>Healthcare Disparities</term><term>Medical Oncology</term><term>Pediatrics</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Age of Onset</term><term>Child</term><term>Cooperative Behavior</term><term>Diffusion of Innovation</term><term>Health Status Disparities</term><term>Humans</term><term>Interdisciplinary Communication</term><term>International Cooperation</term><term>Remission Induction</term><term>Survivors</term><term>Time Factors</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Communication interdisciplinaire</term><term>Comportement coopératif</term><term>Coopération internationale</term><term>Diffusion des innovations</term><term>Disparités de l'état de santé</term><term>Enfant</term><term>Facteurs temps</term><term>Humains</term><term>Induction de rémission</term><term>Jeune adulte</term><term>Résultat thérapeutique</term><term>Survivants</term><term>Tumeurs</term><term>Âge de début</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Advances in the treatment of childhood cancers have resulted in part from the development of national and international collaborative initiatives that have defined biologic determinants and generated risk-adapted therapies that maximize cure while minimizing acute and long-term effects. Currently, more than 80% of children with cancer who are treated with modern multidisciplinary treatments in developed countries are cured; however, of the approximately 160,000 children and adolescents who are diagnosed with cancer every year worldwide, 80% live in low- and middle-income countries (LMICs), where access to quality care is limited and chances of cure are low. In addition, the disease burden is not fully known because of the lack of population-based cancer registries in low-resource countries. Regional and ethnic variations in the incidence of the different childhood cancers suggest unique interactions between genetic and environmental factors that could provide opportunities for etiologic research. Regional collaborative initiatives have been developed in Central and South America and the Caribbean, Africa, the Middle East, Asia, and Oceania. These initiatives integrate regional capacity building, education of health care providers, implementation of intensity-graduated treatments, and establishment of research programs that are adjusted to local capacity and local needs. Together, the existing consortia and regional networks operating in LMICs have the potential to reach out to almost 60% of all children with cancer worldwide. In summary, childhood cancer burden has been shifted toward LMICs and, for that reason, global initiatives directed at pediatric cancer care and control are needed. Regional networks aiming to build capacity while incorporating research on epidemiology, health services, and outcomes should be supported.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Alcasabas, Patricia" sort="Alcasabas, Patricia" uniqKey="Alcasabas P" first="Patricia" last="Alcasabas">Patricia Alcasabas</name><name sortKey="Antillon, Federico" sort="Antillon, Federico" uniqKey="Antillon F" first="Federico" last="Antillon">Federico Antillon</name><name sortKey="Banavali, Shripad" sort="Banavali, Shripad" uniqKey="Banavali S" first="Shripad" last="Banavali">Shripad Banavali</name><name sortKey="Barr, Ronald" sort="Barr, Ronald" uniqKey="Barr R" first="Ronald" last="Barr">Ronald Barr</name><name sortKey="Castillo, Luis" sort="Castillo, Luis" uniqKey="Castillo L" first="Luis" last="Castillo">Luis Castillo</name><name sortKey="Friedrich, Paola" sort="Friedrich, Paola" uniqKey="Friedrich P" first="Paola" last="Friedrich">Paola Friedrich</name><name sortKey="Gross, Thomas" sort="Gross, Thomas" uniqKey="Gross T" first="Thomas" last="Gross">Thomas Gross</name><name sortKey="Harif, Mhammed" sort="Harif, Mhammed" uniqKey="Harif M" first="Mhammed" last="Harif">Mhammed Harif</name><name sortKey="Israels, Trijn" sort="Israels, Trijn" uniqKey="Israels T" first="Trijn" last="Israels">Trijn Israels</name><name sortKey="Jeha, Sima" sort="Jeha, Sima" uniqKey="Jeha S" first="Sima" last="Jeha">Sima Jeha</name><name sortKey="Patte, Catherine" sort="Patte, Catherine" uniqKey="Patte C" first="Catherine" last="Patte">Catherine Patte</name><name sortKey="Pui, Ching Hon" sort="Pui, Ching Hon" uniqKey="Pui C" first="Ching-Hon" last="Pui">Ching-Hon Pui</name><name sortKey="Quah, Thuan Chong" sort="Quah, Thuan Chong" uniqKey="Quah T" first="Thuan Chong" last="Quah">Thuan Chong Quah</name><name sortKey="Rodriguez Galindo, Carlos" sort="Rodriguez Galindo, Carlos" uniqKey="Rodriguez Galindo C" first="Carlos" last="Rodriguez-Galindo">Carlos Rodriguez-Galindo</name><name sortKey="Sullivan, Michael J" sort="Sullivan, Michael J" uniqKey="Sullivan M" first="Michael J." last="Sullivan">Michael J. Sullivan</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002698 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002698 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4979198
|texte= Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26304881" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |